Neoadjuvant PD-(L)1 blockade with or without chemotherapy versus chemotherapy alone in mismatch repair-deficient, potentially resectable stage III-IVA gastric cancer patients: a single-center retrospective study
In potentially resectable gastric cancer patients with MSI-H/dMMR status, PD-(L)1 blockade-based neoadjuvant treatment regimen provided promising clinical benefits and was well tolerated.
Authors
- Xuchen Zhang (ORCID: https://orcid.org/0000-0002-1484-4672)
- Yunqing Chen (ORCID: https://orcid.org/0000-0002-3504-8472)
- Helei Hou (ORCID: https://orcid.org/0000-0001-8502-7461)
- Ning Liu (ORCID: https://orcid.org/0000-0002-7484-0534)
- Wei‐Hua Yan (ORCID: https://orcid.org/0000-0003-1774-7699)
- Chuantao Zhang (ORCID: https://orcid.org/0000-0003-1212-971X)
- Yi Li (ORCID: https://orcid.org/0000-0001-8643-4501)
- Huiyun Wang
- Zhaojian Niu (ORCID: https://orcid.org/0000-0003-3734-8820)
- Shanai Song
Institutions
- Qingdao University (CN)
- Affiliated Hospital of Qingdao University (CN)
Publication Details
- Journal
- World Journal of Surgical Oncology
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1186/s12957-024-03601-4
- Citations
- 4
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.68
Funders
- Natural Science Foundation of Shandong Province